Medications for opioid use disorder during pregnancy: Access and continuity in a state women’s prison facility, 2016-2019

Only 40% of eligible pregnant people with opioid use disorder received either buprenorphine or methadone during incarceration. Fewer than one-third were referred for medications for opioid use disorder when they returned to the community after incarceration. Withdrawal symptoms are common among people whose buprenorphine or methadone are discontinued immediately postpartum during incarceration.